Viewing Study NCT00285090



Ignite Creation Date: 2024-05-05 @ 4:38 PM
Last Modification Date: 2024-10-26 @ 9:22 AM
Study NCT ID: NCT00285090
Status: TERMINATED
Last Update Posted: 2011-12-20
First Post: 2006-01-31

Brief Title: Bone Mineral Density Body Composition and Growth Following Severe Burn Injury
Sponsor: Kathy Prelack PhD RD
Organization: Shriners Hospitals for Children

Study Overview

Official Title: Bone Mineral Density Body Composition and Growth Following Severe Burn Injury
Status: TERMINATED
Status Verified Date: 2011-12
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Lack of volunteers
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The purpose of this study is two-fold The first is to establish that bone mineral density is diminished among children admitted to this regional burn center as compared to healthy non-burned children The second purpose of this study is to examine the short and long-term effects of calcium and vitamin D supplementation in on bone metabolism and accrual in children who have been burned

Specific Aims 1 To measure bone mineral content and bone mineral density and their change during growth in convalescent burned children admitted to a regional burn center and to compare them to normal healthy children 2 To measure lean body mass fat mass total body water in convalescent burned children admitted to a regional burn center and compare them to normal healthy children with focus on how these components of body composition relate to indices of bone mineral content and density 3 To identify alterations in bone metabolism and calcium and vitamin D homeostasis following burn injury and relate these to bone mineral density in burned children 4 To test the effect of short term calcium and vitamin D supplementation on improving bone mineral density bone mineral content and indices of calcium and vitamin D metabolism in acutely burned children
Detailed Description: The 60 acute patients will be randomized into 4 groups Acute patients must be enrolled within 3 weeks of their admission to be eligible for study Treatment is defined as provision of a supplement of 1000 mg elemental calcium with 400 IU of vitamin D daily as available in our standard hospital formulary and deemed appropriate by the pharmacist Group 1 will take the supplement of from the day of enrollment in the study to the time of wound closure Each group will consist of 15 patients Upon enrollment into the study 10 mL of blood will be obtained to measure baseline 25 and 125 vitamin D parathyroid hormone alkaline phosphatase vitamin D binding protein tumor necrosis factor and IL-6 The patients will be randomized into one of 4 groups the early treatment group Group 1 late treatment group Group 2 total treatment group Group 3 and the no treatment group Group 4 Group 1 will take a supplement of 1000 mg calcium with 400 IU of vitamin D daily during their early acute phase of care from the day of enrollment in the study until the time of wound closure Group 2 will take the supplement during their rehabilitation phase of care from the time of wound closure to the time of discharge Group 3 will take the supplement for the entire duration of their stay from the time of enrollment into the study to the time of discharge Group 4 will receive no supplement Patients who have a DXA scan of less than -2 SD units and who are in a group that is not receiving a supplement at that time Groups 1 or 4 will begin supplementation 1000 mg calcium and 400 international units vitamin D as part of routine care They will remain in the study for monitoring and reporting of results Blood levels as described above for baseline assessment will be repeated every 4 weeks for all acute patients during their initial hospital admission At the time of wound closure all acute patients will have their bone mineral content bone mineral density lean body mass fat mass and total body water measured This will be repeated immediately prior to discharge and at their next 2 planned reconstructive admissions approximately 6 months to 1 year and again at 2 years A 10 mL blood draw to measure biochemical indices as described above will be obtained during these repeat hospital admissions as well

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None